Role of adjunctive cariprazine for treatment-resistant depression in patients with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials

Cariprazine is an orally active dopamine D3-preferring D3/D2 receptor and serotonin 5-HT1A receptor partial agonist, being considered as a treatment for refractory MDD. Therefore, we aim to perform the first meta-analysis of current literature, to collate changes in depression from baseline and asse...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Asian journal of psychiatry 2024-05, Vol.95, p.104005-104005, Article 104005
Hauptverfasser:	Ali, Eman, Latif, Fakhar, Mashkoor, Yusra, Sheikh, Ayesha, Iqbal, Amna, Owais, Rabia, Ahmed, Jawad, Naveed, Sadiq, Moeed, Abdul, Ullah, Irfan, Mughal, Sanila
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressive Agents - administration & dosage Antidepressive Agents - adverse effects Cariprazine Depression scores Depressive Disorder, Major - drug therapy Depressive Disorder, Treatment-Resistant - drug therapy Dopamine receptor agonist Drug Therapy, Combination Humans Major Depressive Disorder Outcome Assessment, Health Care Piperazines - administration & dosage Piperazines - adverse effects Piperazines - pharmacology Randomized Controlled Trials Randomized Controlled Trials as Topic Tolerability
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!